Found: 4
Select item for more details and to access through your institution.
The role of incretin receptor agonists in the treatment of obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4178, doi. 10.1111/dom.15796
- By:
- Publication type:
- Article
Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 4, p. 942, doi. 10.1111/bcp.15990
- By:
- Publication type:
- Article
First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist for endothelial protection
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 2, p. 598, doi. 10.1111/bcp.14422
- By:
- Publication type:
- Article
Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 5, p. 465, doi. 10.1007/s40261-017-0497-0
- By:
- Publication type:
- Article